Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

An NO donor approach to neuroprotective and procognitive estrogen therapy overcomes loss of NO synthase function and potentially thrombotic risk.

VandeVrede L, Abdelhamid R, Qin Z, Choi J, Piyankarage S, Luo J, Larson J, Bennett BM, Thatcher GR.

PLoS One. 2013 Aug 16;8(8):e70740. doi: 10.1371/journal.pone.0070740. eCollection 2013.

PMID:
23976955
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Identification of BACE2 as an avid ß-amyloid-degrading protease.

Abdul-Hay SO, Sahara T, McBride M, Kang D, Leissring MA.

Mol Neurodegener. 2012 Sep 17;7:46. doi: 10.1186/1750-1326-7-46.

PMID:
22986058
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

NO-SSRIs: Nitric Oxide Chimera Drugs Incorporating a Selective Serotonin Reuptake Inhibitor.

Abdul-Hay S, Schiefer IT, Chandrasena RE, Li M, Abdelhamid R, Wang YT, Tavassoli E, Michalsen B, Asghodom RT, Luo J, Thatcher GR.

ACS Med Chem Lett. 2011 Sep 8;2(9):656-661.

PMID:
21927645
[PubMed]
Free PMC Article
4.

Inhibition of amyloidogenesis by nonsteroidal anti-inflammatory drugs and their hybrid nitrates.

Schiefer IT, Abdul-Hay S, Wang H, Vanni M, Qin Z, Thatcher GR.

J Med Chem. 2011 Apr 14;54(7):2293-306. doi: 10.1021/jm101450p. Epub 2011 Mar 15.

PMID:
21405086
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

L'Episcopo F, Tirolo C, Caniglia S, Testa N, Serra PA, Impagnatiello F, Morale MC, Marchetti B.

J Neuroinflammation. 2010 Nov 23;7:83. doi: 10.1186/1742-2094-7-83.

PMID:
21092260
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk